Graves hyperthyroidism has a remission rate of 20%-30% with standard antithyroid drug treatment, but long-term use can be problematic. Researchers explored whether adjuvant rituximab would aid remission rates.
A 14-year-old adolescent with epilepsy presents with increasing episodes of nosebleeds, increased rate of speech, leg pain with little exercise, and irritable mood. Learn how delayed diagnosis of Graves disease affected her treatment.
Compared with uninfected individuals, people with HIV controlled with combination antiretroviral therapy are not at increased risk of developing thyroid dysfunction.
Patients with Graves’ disease who took selenium demonstrated improvements in overall quality of life and opthalmologic assessment.
